The Valley Desk

ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationPublished

Intravenous Versus Subcutaneous Induction with Guselkumab: Week 12 and Week 96 Efficacy in GALAXI 2 & 3 and GRAVITI

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published
Subject terms
Long-term Efficacy; Crohn’s Disease; Guselkumab; Intravenous Induction; Subcutaneous Induction
PubMed ID
42946108
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal